Workflow
Thermo Fisher Scientific(TMO)
icon
Search documents
Thermo Fisher Scientific(TMO) - 2024 Q3 - Earnings Call Transcript
2024-10-23 16:07
Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2024 Earnings Conference Call October 23, 2024 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Jack Meehan - Nephron Research Doug Schenkel - Wolfe Research Tycho Peterson - Jefferies Matt Sykes - Goldman Sachs ...
Thermo Fisher (TMO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2024-10-23 14:35
For the quarter ended September 2024, Thermo Fisher Scientific (TMO) reported revenue of $10.6 billion, up 0.2% over the same period last year. EPS came in at $5.28, compared to $5.69 in the year-ago quarter.The reported revenue represents a surprise of -0.42% over the Zacks Consensus Estimate of $10.64 billion. With the consensus EPS estimate being $5.25, the EPS surprise was +0.57%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to ...
Thermo Fisher Q3 Earnings Top Estimates, Revenues Miss, Stock Dips
ZACKS· 2024-10-23 14:21
Thermo Fisher Scientific Inc.'s (TMO) third-quarter 2024 adjusted earnings per share (EPS) of $5.28 beat the Zacks Consensus Estimate by 0.6%. However, the figure decreased 7.2% year over year.The adjusted number excludes certain expenses, including asset amortization costs and certain restructuring costs.GAAP EPS was $4.25, down 3.8% on a year-over-year basis.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the earnings announcement, shares of TMO decreased nearly 2% in the ...
Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'
Seeking Alpha· 2024-10-23 14:05
For Thermo Fisher Scientific Inc. (NYSE: TMO ), I highlighted the downturn in the pharma and biotech industry as well as weak growth in China in my previous article published in January 2024. I anticipate the overall pharmaAnalyst’s Disclosure: I/we have a beneficial long position in the shares of TMO either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no b ...
Thermo Fisher Scientific (TMO) Q3 Earnings Top Estimates
ZACKS· 2024-10-23 12:11
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.28 per share, beating the Zacks Consensus Estimate of $5.25 per share. This compares to earnings of $5.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.57%. A quarter ago, it was expected that this maker of scientific instrument and laboratory supplies would post earnings of $5.13 per share when it actually produced earnings of $5.37, delivering a surpri ...
Thermo Fisher Scientific(TMO) - 2024 Q3 - Quarterly Results
2024-10-23 10:03
Exhibit 99.1 News | --- | --- | |---------------------------------------------------------------------------|--------------------------------------------------------------------------------| | | | | FOR IMMEDIATE RELEASE | | | Media Contact Information: Sandy Pound Thermo Fisher Scientific | Investor Contact Information: Rafael Tejada Thermo Fisher Scientific | | Phone: 781-622-1223 | Phone: 781-622-1356 | | E-mail: sandy.pound@thermofisher.com | E-mail: rafael.tejada@thermofisher.com | Thermo Fisher Scient ...
Lab Consumables Business Research Report 2024-2030 with Focus on 350+ Select Players Including Thermo Fisher Scientific, VITLAB, Bellco Glass, Eppendorf and BRAND Scientific Equipment Among Others
GlobeNewswire News Room· 2024-10-22 13:37
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Lab Consumables - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Lab Consumables is estimated at US$12.7 Million in 2023 and is projected to reach US$17.2 Million by 2030, growing at a CAGR of 4.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The manufacturing and supply of l ...
Thermo Fisher (TMO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2024-10-18 14:20
In its upcoming report, Thermo Fisher Scientific (TMO) is predicted by Wall Street analysts to post quarterly earnings of $5.25 per share, reflecting a decline of 7.7% compared to the same period last year. Revenues are forecasted to be $10.64 billion, representing a year-over-year increase of 0.7%. The consensus EPS estimate for the quarter has undergone an upward revision of 0.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed t ...
Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2024-10-16 15:05
The market expects Thermo Fisher Scientific (TMO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on October 23, 2024, might help the stock move higher if these ...
Robust Analytical Instrument Segment Likely to Aid TMO's Q3 Earnings
ZACKS· 2024-10-14 13:22
Thermo Fisher Scientific Inc. (TMO) is slated to release third-quarter 2024 results on Oct. 23, before market open. Thermo Fisher's second-quarter earnings of $5.37 per share beat the Zacks Consensus Estimate by 4.7%. Its earnings surpassed estimates in each of the trailing four quarters, the average surprise being 3.98%. TMO's Q3 Estimates The Zacks Consensus Estimate for revenues is pegged at $10.64 billion, suggesting 0.6% growth from the prioryear quarter's reported figure. The consensus mark for earnin ...